Back to 
MetLife Investment Management, LLC
MetLife Investment Management, LLC
INO
Showing 0 of 18 quarters
Position history for MetLife Investment Management, LLC's holdings in Inovio Pharmaceuticals, Inc.
No. MetLife Investment Management exited its INO (Inovio Pharmaceuticals) position in Q2 2023. Its Q1 2023 13F listed 126,566 shares worth $103,784. MetLife Investment Management already held INO in its Q1 2019 13F, the earliest on record, and held it in 16 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.